Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MYD88 somatic mutations in MALT lymphomas.

Literature DB >> 22640364

MYD88 somatic mutations in MALT lymphomas.

Zhi-Ming Li, Andrea Rinaldi, Andrea Cavalli, Afua A Mensah, Maurilio Ponzoni, Randy D Gascoyne, Govind Bhagat, Emanuele Zucca, Francesco Bertoni.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2012 PMID： 22640364 DOI： 10.1111/j.1365-2141.2012.09176.x

Source DB: PubMed Journal: Br J Haematol ISSN： 0007-1048 Impact factor: 6.998

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies.

Authors: Tariq I Mughal; Saulius Girnius; Steven T Rosen; Shaji Kumar; Adrian Wiestner; Omar Abdel-Wahab; Jean-Jacques Kiladjian; Wyndham H Wilson; Richard A Van Etten
Journal: Leuk Lymphoma Date: 2014-02-17

Review 2. Targeting pathological B cell receptor signalling in lymphoid malignancies.

Authors: Ryan M Young; Louis M Staudt
Journal: Nat Rev Drug Discov Date: 2013-03 Impact factor: 84.694

3. MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.

Authors: Fatima Hamadeh; Stephen P MacNamara; Nadine S Aguilera; Steven H Swerdlow; James R Cook
Journal: Mod Pathol Date: 2014-09-12 Impact factor: 7.842

4. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy.

Authors: Priscilla N Kelly; Donna L Romero; Yibin Yang; Arthur L Shaffer; Divya Chaudhary; Shaughnessy Robinson; Wenyan Miao; Lixin Rui; William F Westlin; Rosana Kapeller; Louis M Staudt
Journal: J Exp Med Date: 2015-11-30 Impact factor: 14.307

Review 5. Molecular Pathogenesis of MALT Lymphoma.

Authors: Katharina Troppan; Kerstin Wenzl; Peter Neumeister; Alexander Deutsch
Journal: Gastroenterol Res Pract Date: 2015-04-01 Impact factor: 2.260

6. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.

Authors: Andi K Cani; Moaaz Soliman; Daniel H Hovelson; Chia-Jen Liu; Andrew S McDaniel; Michaela J Haller; Jarred V Bratley; Samantha E Rahrig; Qiang Li; César A Briceño; Scott A Tomlins; Rajesh C Rao
Journal: Mod Pathol Date: 2016-04-22 Impact factor: 7.842

MYD88 somatic mutations in MALT lymphomas.

Review 1. Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies.

Review 2. Targeting pathological B cell receptor signalling in lymphoid malignancies.

3. MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.

4. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy.

Review 5. Molecular Pathogenesis of MALT Lymphoma.

6. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.

Review 7. Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma.

Review 8. Recent advances in understanding the biology of marginal zone lymphoma.

Review 9. MYD88 in the driver's seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications.

10. L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma.